Cargando…

A Severe Case of Cutaneous Adverse Drug Reaction Secondary to a Novice Drug: Idelalisib

Phosphatidylinositol 3-kinase δ (PIK3δ) is a tyrosine kinase essential for B cell survival, making it an important target in the treatment of chronic lymphocytic leukemia. Idelalisib is an inhibitor of PIK3δ demonstrating initial success in disease response, but is now shown to have a decreased over...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gabriel, Joseph Gabriel, Kapila, Aaysha, Gonzalez-Estrada, Alexei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446100/ https://www.ncbi.nlm.nih.gov/pubmed/28589155 http://dx.doi.org/10.1177/2324709617711463

Ejemplares similares

The assessment of severe cutaneous adverse drug reactions
por: Copaescu, Ana M, et al.
Publicado: (2022)

Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions
por: Orime, Mari
Publicado: (2017)

Recent Advances in Severe Cutaneous Adverse Drug Reaction
por: Das, Sudip, et al.
Publicado: (2018)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Severe Cutaneous Adverse Drug Reactions: A Clinicoepidemiological Study
por: Sasidharanpillai, Sarita, et al.
Publicado: (2015)

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
por: Lin Choo, Karen Jui, et al.
Publicado: (2014)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Severe Cutaneous Adverse Reactions Caused by Anti-Tubercular Drugs
por: Kim, Sang-Heon
Publicado: (2021)

Epidemiology of cutaneous adverse drug reactions
por: Mockenhaupt, M.
Publicado: (2017)

Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients
por: Jin, Hyun Jung, et al.
Publicado: (2020)

Sutton's law and severe cutaneous adverse drug reactions: Is the money in the blister?
por: Chow, Timothy G., et al.
Publicado: (2021)

Severe cutaneous adverse drug reactions of Chinese inpatients: a meta-analysis
por: Qiancheng, Deng, et al.
Publicado: (2017)

Cutaneous Adverse Drug Reactions in Dogs Treated with Antiepileptic Drugs
por: Koch, Tina, et al.
Publicado: (2016)

Causality Assessment of Cutaneous Adverse Drug Reactions
por: Son, Young-Min, et al.
Publicado: (2011)

Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014)

Unusual and Interesting Adverse Cutaneous Drug Reactions
por: Masatkar, Vaishali, et al.
Publicado: (2018)

Controversies in the Management of Cutaneous Adverse Drug Reactions
por: Manchanda, Yashpal, et al.
Publicado: (2018)

Dermoscopic Aspects of Cutaneous Adverse Drug Reactions
por: Rossi, Gabriela, et al.
Publicado: (2021)

Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs
por: Lee, Suh-Young, et al.
Publicado: (2018)

Identification of drug-specific public TCR driving severe cutaneous adverse reactions
por: Pan, Ren-You, et al.
Publicado: (2019)

The Role of Frozen Section in the Rapid Diagnosis of Severe Cutaneous Adverse Drug Reactions
por: Nicholas, Rajam, et al.
Publicado: (2021)

Severe Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Saudi Arabia
por: AlJasser, Mohammed I.
Publicado: (2023)

In Vitro Release of Interferon-Gamma from Peripheral Blood Lymphocytes in Cutaneous Adverse Drug Reactions
por: Goldberg, Ilan, et al.
Publicado: (2012)

Vancomycin-Associated Spontaneous Cutaneous Adverse Drug Reactions
por: An, So-Yeon, et al.
Publicado: (2011)

An Update on Adverse Cutaneous Drug Reactions in HIV/AIDS
por: Hoosen, Koraisha, et al.
Publicado: (2019)

Tolerated drugs in subjects with severe cutaneous adverse reactions (SCARs) induced by anticonvulsants and review of the literature
por: De Luca, Fabrizio, et al.
Publicado: (2017)

Probable cutaneous adverse drug reaction to piroxicam in a cat
por: Young, Amanda J, et al.
Publicado: (2018)

HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese
por: Nguyen, Dinh Van, et al.
Publicado: (2015)

Epidemiology of Severe Cutaneous Adverse Drug Reaction and Its HLA Association among Pediatrics
por: Esmaeilzadeh, Hossein, et al.
Publicado: (2019)

Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
por: Valeyrie-Allanore, Laurence, et al.
Publicado: (2014)

Severe Cutaneous Adverse Reactions to Antiepileptic Drugs: A Nationwide Registry-Based Study in Korea
por: Park, Chan Sun, et al.
Publicado: (2019)

Cutaneous Adverse Drug Reactions to Targeted Chemotherapeutic Drugs: A Clinico-Epidemiological Study
por: Saini, Kriteeka, et al.
Publicado: (2019)

In Silico Approach to Predict Severe Cutaneous Adverse Reactions Using the Japanese Adverse Drug Event Report Database
por: Ambe, Kaori, et al.
Publicado: (2021)

Management of adverse events associated with idelalisib treatment: expert panel opinion
por: Coutré, Steven E., et al.
Publicado: (2015)

Idelalisib: Practical Tools for Identifying and Managing Adverse Events in Clinical Practice
por: Driscoll, Nancy
Publicado: (2016)

Severe adverse drug reaction to allopurinol
por: Lucas, Grace, et al.
Publicado: (2022)

Treatments for Severe Cutaneous Adverse Reactions
por: Cho, Yung-Tsu, et al.
Publicado: (2017)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

Cutaneous adverse drug reactions in Indian population: A systematic review
por: Patel, Tejas K, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7e96jpre3nit9t7jp1i0l3cesa